Osteoporosis International

, Volume 15, Issue 11, pp 903–908

Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture

  • Paul N. Tasker
  • Omar M. E. Albagha
  • Clifford B. Masson
  • David M. Reid
  • Stuart H. Ralston
Original Article

Abstract

The TNFRSF1B gene, which encodes the p75 TNF receptor, is a strong functional and positional candidate gene for susceptibility to osteoporosis. In a previous study, we reported that polymorphic variation in the 3’ untranslated region of TNFRSF1B was associated with femoral neck bone mineral density (BMD) in a population-based cohort of Scottish women. In order to further explore the role of TNFRSF1B as a candidate gene for osteoporosis, we have now studied the relationship between a promoter polymorphism in the TNFRSF1B gene and BMD, and determined whether this polymorphism interacts with other polymorphisms in TNFRSF1B to regulate bone mass, bone loss, and osteoporotic fracture. Analysis of individual polymorphisms showed weak associations between the G593A, T598G and T620C polymorphisms and femoral neck BMD (P=0.05–0.017). On haplotype analysis, the only significant association we observed was with FN BMD when haplotypes were grouped according to presence or absence of A593-T598-C620 alleles in the 3’ UTR (0.897±0.005 versus 0.841±0.01; P<0.0001). These data show that allelic variation within the TNFRSF1B gene contributes to the genetic regulation of FN-BMD and show that it is the ATC haplotype in the 3’UTR region of the gene, rather than other polymorphic variants, that seem to be responsible for the effects observed.

Keywords

Genetic Haplotype Osteoporosis Polymorphism 

References

  1. 1.
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141PubMedGoogle Scholar
  2. 2.
    Ralston SH (2002) Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab 87:2460–2466Google Scholar
  3. 3.
    Wilson SG, Reed PW, Bansal A, Chiano M, Lindersson M, Langdown M, Prince RL, Thompson D, Thompson E, Bailey M et al. (2003) Comparison of genome screens for two independent cohorts provides replication of suggestive linkage of bone mineral density to 3p21 and 1p36. Am J Hum Genet 72:144–155CrossRefPubMedGoogle Scholar
  4. 4.
    Devoto M, Specchia C, Li HH, Caminis J, Tenenhouse A, Rodriguez H, Spotila LD (2001) Variance component linkage analysis indicates a QTL for femoral neck bone mineral density on chromosome 1p36. Hum Mol Genet 10:2447–2452CrossRefPubMedGoogle Scholar
  5. 5.
    Spotila LD, Devoto M, Caminis J, Kosich R, Korkko J, Ott J, Tenenhouse A, Prockop DJ (1998) Suggested linkage of low bone density to chromosome 1p36 is extended to a second cohort of sib pairs. Bone 23:S277–S277 (abstract)Google Scholar
  6. 6.
    Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL (2000) Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275:27307–27310PubMedGoogle Scholar
  7. 7.
    Spotila LD, Rodriguez H, Koch M, Adams K, Caminis J, Tenenhouse HS, Tenenhouse A (2000) Association of a polymorphism in the TNFR2 gene with low bone mineral density. J Bone Miner Res 15:1376–1383PubMedGoogle Scholar
  8. 8.
    Albagha OME, Tasker PN, McGuigan FEA, Reid DM, Ralston SH (2002) Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet 11:2289–2295CrossRefPubMedGoogle Scholar
  9. 9.
    Keen L, Wood N, Olomolaiye O, Bidwell J (1999) A bi-allelic VNTR in the human TNFR2 (p75) gene promoter. Genes Immun 1:164–165PubMedGoogle Scholar
  10. 10.
    Barton A, John S, Ollier WE, Silman A, Worthington J (2001) Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthr Rheum 44:61–65CrossRefGoogle Scholar
  11. 11.
    Isamil AA, O’Neil TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ and EPOS Study Group (2002) Validity of self-report of fractures: results from a prospective study in men and women across Europe. Osteoporos Int 11:248–254CrossRefGoogle Scholar
  12. 12.
    Niu T, Qin ZS, Xu X, Liu JS (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 70:157–169CrossRefPubMedGoogle Scholar
  13. 13.
    Terwilliger JD, Ott J (1994) Handbook of human genetic linkage. Johns Hopkins University Press, Baltimore & London, pp 235–242Google Scholar
  14. 14.
    Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Statist Med 16:2529–2542CrossRefGoogle Scholar
  15. 15.
    Devoto M, Shimoya K, Caminis J, Ott J, Tenenhouse A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ et al. (1998) First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6:151–157PubMedGoogle Scholar
  16. 16.
    Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J (2001) The 3’ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21:721–730PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  • Paul N. Tasker
    • 1
  • Omar M. E. Albagha
    • 1
  • Clifford B. Masson
    • 1
  • David M. Reid
    • 1
  • Stuart H. Ralston
    • 1
  1. 1.Department of Medicine and TherapeuticsUniversity of AberdeenAberdeenUK

Personalised recommendations